Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 19 studies | 23% ± 7% | |
endothelial cell | 18 studies | 27% ± 10% | |
capillary endothelial cell | 7 studies | 24% ± 4% | |
endothelial cell of artery | 7 studies | 26% ± 7% | |
endothelial cell of vascular tree | 7 studies | 20% ± 4% | |
vein endothelial cell | 6 studies | 21% ± 4% | |
connective tissue cell | 5 studies | 32% ± 12% | |
ciliated cell | 5 studies | 23% ± 4% | |
pericyte | 4 studies | 22% ± 3% | |
epithelial cell | 4 studies | 35% ± 13% | |
type I pneumocyte | 4 studies | 21% ± 6% | |
basal cell | 4 studies | 22% ± 4% | |
astrocyte | 3 studies | 26% ± 5% | |
glutamatergic neuron | 3 studies | 20% ± 2% | |
goblet cell | 3 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
intestine | 3 studies | 22% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 10343.98 | 1809 / 1809 | 100% | 144.80 | 472 / 472 |
ovary | 100% | 6146.53 | 180 / 180 | 100% | 80.37 | 429 / 430 |
breast | 100% | 8286.60 | 459 / 459 | 100% | 92.08 | 1114 / 1118 |
lung | 100% | 6516.85 | 577 / 578 | 100% | 102.46 | 1152 / 1155 |
intestine | 100% | 5439.07 | 965 / 966 | 99% | 89.31 | 523 / 527 |
esophagus | 100% | 5487.75 | 1445 / 1445 | 99% | 93.31 | 181 / 183 |
uterus | 100% | 7334.42 | 170 / 170 | 99% | 66.06 | 453 / 459 |
kidney | 100% | 4144.39 | 89 / 89 | 99% | 85.75 | 889 / 901 |
stomach | 100% | 4233.25 | 359 / 359 | 99% | 79.61 | 282 / 286 |
pancreas | 99% | 3023.62 | 324 / 328 | 99% | 89.32 | 177 / 178 |
prostate | 100% | 5269.47 | 244 / 245 | 98% | 54.15 | 493 / 502 |
bladder | 100% | 5808.24 | 21 / 21 | 97% | 70.24 | 488 / 504 |
thymus | 100% | 5944.89 | 653 / 653 | 96% | 57.75 | 578 / 605 |
adrenal gland | 100% | 5766.15 | 258 / 258 | 91% | 45.64 | 210 / 230 |
brain | 84% | 2057.06 | 2229 / 2642 | 77% | 51.97 | 543 / 705 |
liver | 62% | 1075.64 | 139 / 226 | 71% | 26.07 | 288 / 406 |
adipose | 100% | 9534.29 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 80.60 | 80 / 80 |
ureter | 0% | 0 | 0 / 0 | 100% | 44.21 | 1 / 1 |
blood vessel | 100% | 8109.05 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 5943.09 | 859 / 861 | 0% | 0 | 0 / 0 |
spleen | 99% | 3000.80 | 239 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 53.19 | 44 / 45 |
muscle | 91% | 1936.61 | 732 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 14% | 2.40 | 4 / 29 |
peripheral blood | 9% | 126.12 | 85 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006457 | Biological process | protein folding |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0003755 | Molecular function | peptidyl-prolyl cis-trans isomerase activity |
GO_0005509 | Molecular function | calcium ion binding |
Gene name | FKBP9 |
Protein name | Peptidyl-prolyl cis-trans isomerase FKBP9 (PPIase FKBP9) (EC 5.2.1.8) (63 kDa FK506-binding protein) (63 kDa FKBP) (FKBP-63) (FK506-binding protein 9) (FKBP-9) (Rotamase) peptidylprolyl isomerase (EC 5.2.1.8) |
Synonyms | FKBP63 tcag7.1016 FKBP60 |
Description | FUNCTION: PPIases accelerate the folding of proteins during protein synthesis. |
Accessions | A0A090N8P3 ENST00000490776.3 [O95302-2] ENST00000538336.5 [O95302-3] O95302 ENST00000418354.5 ENST00000242209.9 [O95302-1] C9J4P8 A7YQ73 |